HEADER TRANSFERASE 19-JAN-16 5HOR TITLE CRYSTAL STRUCTURE OF C-MET-M1250T IN COMPLEX WITH SAR125844. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21 KEYWDS TRANSFERASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR F.VALLEE,J.HOUTMANN,J.-P.MARQUETTE REVDAT 4 08-MAY-24 5HOR 1 REMARK REVDAT 3 16-OCT-19 5HOR 1 REMARK REVDAT 2 24-OCT-18 5HOR 1 COMPND SOURCE REVDAT 1 23-NOV-16 5HOR 0 JRNL AUTH A.UGOLINI,M.KENIGSBERG,A.RAK,F.VALLEE,J.HOUTMANN,M.LOWINSKI, JRNL AUTH 2 C.CAPDEVILA,J.KHIDER,E.ALBERT,N.MARTINET,C.NEMECEK, JRNL AUTH 3 S.GRAPINET,E.BACQUE,M.ROESNER,C.DELAISI,L.CALVET,F.BONCHE, JRNL AUTH 4 D.SEMIOND,C.EGILE,H.GOULAOUIC,L.SCHIO JRNL TITL DISCOVERY AND PHARMACOKINETIC AND PHARMACOLOGICAL PROPERTIES JRNL TITL 2 OF THE POTENT AND SELECTIVE MET KINASE INHIBITOR JRNL TITL 3 1-{6-[6-(4-FLUOROPHENYL)-[1,2,4]TRIAZOLO[4, JRNL TITL 4 3-B]PYRIDAZIN-3-YLSULFANYL]BENZOTHIAZOL-2-YL}-3-(2-MORPHOLIN JRNL TITL 5 -4-YLETHYL)UREA (SAR125844). JRNL REF J.MED.CHEM. V. 59 7066 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27355974 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00280 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 16185 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1956 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 95 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HOR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000217452. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07230 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16185 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 39.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS 100MM, MPD 20%, PH8.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.51000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.31000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.49500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.31000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.51000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.49500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 ASN A 1059 REMARK 465 PRO A 1060 REMARK 465 GLU A 1061 REMARK 465 LEU A 1062 REMARK 465 VAL A 1063 REMARK 465 SER A 1074 REMARK 465 SER A 1075 REMARK 465 LEU A 1076 REMARK 465 ILE A 1077 REMARK 465 VAL A 1078 REMARK 465 HIS A 1079 REMARK 465 PHE A 1080 REMARK 465 ASN A 1081 REMARK 465 GLU A 1082 REMARK 465 VAL A 1083 REMARK 465 ILE A 1084 REMARK 465 GLY A 1085 REMARK 465 ARG A 1086 REMARK 465 GLY A 1087 REMARK 465 HIS A 1088 REMARK 465 PHE A 1089 REMARK 465 LEU A 1098 REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 LYS A 1103 REMARK 465 LEU A 1112 REMARK 465 ASN A 1113 REMARK 465 ARG A 1114 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1118 REMARK 465 GLY A 1119 REMARK 465 GLU A 1120 REMARK 465 TYR A 1230 REMARK 465 ASP A 1231 REMARK 465 LYS A 1232 REMARK 465 GLU A 1233 REMARK 465 PHE A 1234 REMARK 465 ASP A 1235 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 465 LYS A 1244 REMARK 465 VAL A 1357 REMARK 465 ASN A 1358 REMARK 465 VAL A 1359 REMARK 465 LYS A 1360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A1229 CG SD CE REMARK 470 LEU A1245 CG CD1 CD2 REMARK 470 VAL A1287 O REMARK 470 TYR A1356 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB CYS A 1107 O HOH A 1585 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1560 O HOH A 1580 4556 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE A1194 C LEU A1195 N -0.138 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A1094 -177.97 -55.78 REMARK 500 SER A1149 81.04 -153.65 REMARK 500 SER A1152 -26.63 -173.78 REMARK 500 ARG A1203 -11.98 81.49 REMARK 500 ASP A1204 39.07 -140.37 REMARK 500 ALA A1221 -148.70 -124.94 REMARK 500 GLN A1258 16.94 50.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 63K A 1401 DBREF 5HOR A 1049 1360 UNP P08581 MET_HUMAN 1049 1360 SEQADV 5HOR PHE A 1194 UNP P08581 TYR 1194 ENGINEERED MUTATION SEQADV 5HOR PHE A 1234 UNP P08581 TYR 1234 ENGINEERED MUTATION SEQADV 5HOR ASP A 1235 UNP P08581 TYR 1235 ENGINEERED MUTATION SEQADV 5HOR THR A 1250 UNP P08581 MET 1250 ENGINEERED MUTATION SEQRES 1 A 312 ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU SEQRES 2 A 312 LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SEQRES 3 A 312 SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY SEQRES 4 A 312 HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN SEQRES 5 A 312 ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN SEQRES 6 A 312 ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR SEQRES 7 A 312 GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL SEQRES 8 A 312 LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER SEQRES 9 A 312 PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU SEQRES 10 A 312 ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL SEQRES 11 A 312 LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY SEQRES 12 A 312 MET LYS PHE LEU ALA SER LYS LYS PHE VAL HIS ARG ASP SEQRES 13 A 312 LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR SEQRES 14 A 312 VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR SEQRES 15 A 312 ASP LYS GLU PHE ASP SER VAL HIS ASN LYS THR GLY ALA SEQRES 16 A 312 LYS LEU PRO VAL LYS TRP THR ALA LEU GLU SER LEU GLN SEQRES 17 A 312 THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SER PHE SEQRES 18 A 312 GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO SEQRES 19 A 312 PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR SEQRES 20 A 312 LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS SEQRES 21 A 312 PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS SEQRES 22 A 312 PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SEQRES 23 A 312 SER ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY GLU SEQRES 24 A 312 HIS TYR VAL HIS VAL ASN ALA THR TYR VAL ASN VAL LYS HET 63K A1401 38 HETNAM 63K 1-(6-{[6-(4-FLUOROPHENYL)[1,2,4]TRIAZOLO[4,3- HETNAM 2 63K B]PYRIDAZIN-3-YL]SULFANYL}-1,3-BENZOTHIAZOL-2-YL)-3- HETNAM 3 63K [2-(MORPHOLIN-4-YL)ETHYL]UREA FORMUL 2 63K C25 H23 F N8 O2 S2 FORMUL 3 HOH *95(H2 O) HELIX 1 AA1 SER A 1122 PHE A 1134 1 13 HELIX 2 AA2 LEU A 1165 ASN A 1171 1 7 HELIX 3 AA3 THR A 1177 LYS A 1198 1 22 HELIX 4 AA4 ALA A 1206 ARG A 1208 5 3 HELIX 5 AA5 PHE A 1223 ARG A 1227 5 5 HELIX 6 AA6 PRO A 1246 THR A 1250 5 5 HELIX 7 AA7 ALA A 1251 GLN A 1258 1 8 HELIX 8 AA8 THR A 1261 THR A 1278 1 18 HELIX 9 AA9 ASN A 1288 PHE A 1290 5 3 HELIX 10 AB1 ASP A 1291 GLN A 1298 1 8 HELIX 11 AB2 PRO A 1309 TRP A 1320 1 12 HELIX 12 AB3 LYS A 1323 ARG A 1327 5 5 HELIX 13 AB4 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 4 VAL A1092 TYR A1093 0 SHEET 2 AA1 4 CYS A1107 LYS A1110 -1 O VAL A1109 N TYR A1093 SHEET 3 AA1 4 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 4 AA1 4 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 AA2 3 GLY A1163 ASP A1164 0 SHEET 2 AA2 3 CYS A1210 LEU A1212 -1 O LEU A1212 N GLY A1163 SHEET 3 AA2 3 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 CISPEP 1 ARG A 1148 SER A 1149 0 -9.46 CISPEP 2 SER A 1149 GLU A 1150 0 1.42 CISPEP 3 SER A 1152 PRO A 1153 0 -2.90 CISPEP 4 LEU A 1245 PRO A 1246 0 -18.86 SITE 1 AC1 16 VAL A1092 ALA A1108 LEU A1157 PRO A1158 SITE 2 AC1 16 TYR A1159 MET A1160 LYS A1161 HIS A1162 SITE 3 AC1 16 GLY A1163 ASP A1164 ASN A1167 ARG A1208 SITE 4 AC1 16 MET A1211 ALA A1221 ASP A1222 ALA A1226 CRYST1 43.020 46.990 156.620 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023245 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021281 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006385 0.00000